title: Rotavirus vaccines: update on global impact and future priorities.
abstract: Early rotavirus vaccine adopter countries in the Americas, Europe, and in Australia have documented substantial declines in rotavirus disease burden following the introduction of vaccination.  However, the full public health impact of rotavirus vaccines has not been realized as they have not been introduced into routine immunization programs in countries of Africa and Asia with the highest rotavirus disease morbidity and mortality burden.  In this article, we review the epidemiology of rotavirus disease, the development and current status of rotavirus vaccines including newly available vaccine impact data from early-introducer countries, and future priorities for implementation and monitoring of rotavirus vaccination programs in developing countries.
authors: Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA. cyen@cdc.gov
authors: Catherine
authors: C
authors: Yen
authors: Jacqueline E
authors: JE
authors: Tate
authors: Manish M
authors: MM
authors: Patel
authors: Margaret M
authors: MM
authors: Cortese
authors: Benjamin
authors: B
authors: Lopman
authors: Jessica
authors: J
authors: Fleming
authors: Kristen
authors: K
authors: Lewis
authors: Baoming
authors: B
authors: Jiang
authors: Jon
authors: J
authors: Gentsch
authors: Duncan
authors: D
authors: Steele
authors: Umesh D
authors: UD
authors: Parashar
mesh_terms: D002675:Child, Preschool; D003906:Developing Countries; D005759:Gastroenteritis / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control / Q000821:virology; D006801:Humans; D017589:Immunization Programs / Q000706:statistics & numerical data*; D007223:Infant; D012401:Rotavirus / Q000276:immunology*; D012400:Rotavirus Infections / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control / Q000821:virology; D022243:Rotavirus Vaccines / Q000276:immunology / Q000627:therapeutic use*; D014611:Vaccination
chemical_list: D022243:Rotavirus Vaccines